05/04/2023
Metastatic cancer patients have fewer treatment options and much poorer outcomes than patientes diagnosed at earlier stages. Sam Mazin, cofounder and CTO of RefleXion Medical, talks with SROA about his hopes and plans for his company’s SCINTIX technology to treat metastatic disease. SCINTIX received FDA clearance in February 2023.
Website: RefleXion Medical
Comments (3)
More Episodes
All Episodes>>
Get this podcast on your phone, Free
Create Your Podcast In Minutes
- Full-featured podcast site
- Unlimited storage and bandwidth
- Comprehensive podcast stats
- Distribute to Apple Podcasts, Spotify, and more
- Make money with your podcast
It is Free
